Dosidal · Switzerland

Incruse Ellipta, einzeldosiertes Pulver zur Inhalation

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:65091 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 65091
atc: R03BB07
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2014-09-29
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: R03BB07
authorisation_number: 65091
form: PUINE
holder: GlaxoSmithKline AG
holder_partner_nr: 1000930
it_number: 03.04.3.
name: Incruse Ellipta, einzeldosiertes Pulver zur Inhalation
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
VrvQg7O9-JQNNucTJSoEdtGuW5Q_LX3J6MP_I2It4ICyTUWWOQx-DYixJuuV5eN_5z3DT_-QHEF60qjjUXInwg
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:65091 · Related records in other markets · Dosidal